India reviews dengue, malaria preparedness
Analysis based on 6 articles · First reported Jun 18, 2026 · Last updated Jun 18, 2026
The review of dengue and malaria preparedness in India could positively impact the healthcare and pharmaceutical industries by increasing demand for related medicines, diagnostic kits, and medical supplies. Improved public health outcomes could also lead to a more stable workforce and consumer base, indirectly benefiting various sectors of the Indian economy.
Union Health Minister Jagad Prakash Nadda chaired a high-level meeting with officials from the Bangladesh — Ministry of Health and Family Welfare to review India's preparedness for dengue and malaria ahead of the monsoon season. The meeting emphasized the need for vigilance, coordinated efforts between central and state governments, and strengthening surveillance systems for early detection and control of mosquito-borne diseases. Jagad Prakash Nadda instructed hospitals to ensure adequate availability of medicines, diagnostic facilities, blood components, hospital beds, and trained healthcare personnel. He also called for intensified vector control activities, public awareness campaigns, and the development of district-specific micro-plans for high-risk areas. The review also highlighted India's significant progress in reducing malaria burden, with an almost 80% decline in cases and deaths between 2015 and 2025, leading to India's exit from the World Health Organization's High Burden to High Impact group in 2024.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard